The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The Opposition has renewed calls to fund the B strain of the meningococcal vaccine after six out of the seven recorded cases ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

A large surveillance study suggests that an extra pneumococcal vaccine dose for new care home residents can significantly ...

Vaccinating children well in advance allows time for the vaccines to provide the necessary protection before they are exposed ...

American children’s health has declined profoundly over the past few decades, a new study shows, and the issues are so ...

GSK is currently the market leader in the meningococcal vaccine market, racking up sales of £1.26 billion (almost $1.6 billion) last year across the Bexsero and Menveo brands, but is having to ...

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

Kochi: Ernakulam govt medical college will open an adult immunisation clinic on Monday. The clinic will provide vaccines ...

Gonorrhoea cases remain alarmingly high in Scotland, a new report has found, with a spike among older men prompting the ...

The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...